Press Release

Printer Friendly Version View printer-friendly version
 « Back
Pernix Therapeutics to Present at RBC Capital Markets 2016 Global Healthcare Conference
Download PDF Download PDF

MORRISTOWN, N.J., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman and Chief Executive Officer, and Sanjay Patel, Chief Financial Officer, will present at the RBC Capital Markets 2016 Global Healthcare Conference, as follows.

Date: Wednesday, February 24, 2016
Time: 1:35 PM EST
Location:                         New York, NY - The New York Palace Hotel 

About Pernix Therapeutics

Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and pain management, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its Pernix sales force and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.

To learn more about Pernix Therapeutics, visit

Investor Relations
Sanjay Patel, (800) 793-2145 ext. 1009
Chief Financial Officer

Matthew P. Duffy, 212.915.0685
LifeSci Advisors, LLC

Primary Logo

Pernix Therapeutics Holdings, Inc.